Cystic fibrosis : a decade of progress
(c) 1999 Prous Science. All rights reserved..
Cystic fibrosis (CF) is an autosomal recessive, multisystem disorder which greatly reduces the lifespan of its victims, largely by gradual, infection-driven destruction of the lungs. Advances in therapy to date have improved median survival from less than 10 years to over 30 years of age. New scientific advances in the past 10 years, notably discovery of the CF gene and increasing understanding of its protein product, hold forth hope of even further therapeutic advances. This review will highlight the clinical characteristics of CF, current standard therapies and directions of ongoing research.
| Errataetall: | |
|---|---|
| Medienart: |
Artikel |
| Erscheinungsjahr: |
1999 |
|---|---|
| Erschienen: |
1999 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
|---|---|
| Enthalten in: |
Drugs of today (Barcelona, Spain : 1998) - 35(1999), 11 vom: 13. Nov., Seite 835-48 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Allen, E D [VerfasserIn] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 23.10.2003 Date Revised 07.11.2019 published: Print ErratumIn: Drugs Today (Barc). 2000 Apr;36(4):263 Citation Status PubMed-not-MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM127203699 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM127203699 | ||
| 003 | DE-627 | ||
| 005 | 20231222213500.0 | ||
| 007 | tu | ||
| 008 | 231222s1999 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0424.xml |
| 035 | |a (DE-627)NLM127203699 | ||
| 035 | |a (NLM)12973375 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Allen, E D |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cystic fibrosis |b a decade of progress |
| 264 | 1 | |c 1999 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 23.10.2003 | ||
| 500 | |a Date Revised 07.11.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a ErratumIn: Drugs Today (Barc). 2000 Apr;36(4):263 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a (c) 1999 Prous Science. All rights reserved. | ||
| 520 | |a Cystic fibrosis (CF) is an autosomal recessive, multisystem disorder which greatly reduces the lifespan of its victims, largely by gradual, infection-driven destruction of the lungs. Advances in therapy to date have improved median survival from less than 10 years to over 30 years of age. New scientific advances in the past 10 years, notably discovery of the CF gene and increasing understanding of its protein product, hold forth hope of even further therapeutic advances. This review will highlight the clinical characteristics of CF, current standard therapies and directions of ongoing research | ||
| 650 | 4 | |a Journal Article | |
| 773 | 0 | 8 | |i Enthalten in |t Drugs of today (Barcelona, Spain : 1998) |d 1998 |g 35(1999), 11 vom: 13. Nov., Seite 835-48 |w (DE-627)NLM123139600 |x 1699-3993 |7 nnns |
| 773 | 1 | 8 | |g volume:35 |g year:1999 |g number:11 |g day:13 |g month:11 |g pages:835-48 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 35 |j 1999 |e 11 |b 13 |c 11 |h 835-48 | ||